← Open Payments lookup

ERNEST KENDRICK: Open Payments

NPI 1124012067 · MISSOURI CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,126 in 40 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,126

Food & beverage: $1,126
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc8$219
ABBVIE INC.10$209
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$176
Supernus Pharmaceuticals, Inc.1$124
Axsome Therapeutics, Inc.4$124
Teva Pharmaceuticals USA, Inc.1$116
Otsuka America Pharmaceutical, Inc.3$56
Vanda Pharmaceuticals Inc.2$47
E.R. Squibb & Sons, L.L.C.1$32
Takeda Pharmaceuticals U.S.A., Inc.1$23

Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, Qelbree, Auvelity, AUSTEDO XR, SPRAVATO, REXULTI.

Industry payments across TX — which companies pay providers there.